サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562262

欧州のトランスフェクション試薬・機器：2030年までの市場予測 - 地域分析 - 製品、手法、用途、エンドユーザー別

Europe Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application, and End User

出版日
ページ情報
英文 112 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
欧州のトランスフェクション試薬・機器：2030年までの市場予測 - 地域分析 - 製品、手法、用途、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 112 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のトランスフェクション試薬・機器市場は、2022年に3億604万米ドルと評価され、2030年には5億5,546万米ドルに達すると予測され、2022年から2030年までのCAGRは7.7%と推定されます。

企業による戦略的取り組みが欧州のトランスフェクション試薬・機器市場を牽引

トランスフェクションは、アデノウイルス、アデノ随伴ウイルス、レンチウイルスを含むウイルスベクターを開発するプロセス全体における複雑なステップです。製造プロセスがスケールアップされるにつれて、一過性のトランスフェクションもまたスケールアップされなければならないです。プロセス装置ベンダー、医薬品開発業者、原料供給業者は、ウイルスベクター製造プロセスの迅速な開発とスケールアップのために、費用対効果が高く、実用的で、プラットフォーム化可能なソリューションを開発するための共同研究に注力しています。小規模であれば、計画された材料量と移送・混合時間により、複数のプラスミドで細胞をトランスフェクションすることは可能です。スケールアップには、トランスフェクションのステップを工業化する経験が必要です。しかし、プロセスをより大きなレベルにスケールアップするために必要な細胞培養培地とトランスフェクション試薬の量は、現実的でない場合があり、最適化の必要性が強調されます。それにもかかわらず、生産規模の拡大は、ウイルスベクターの需要の急増に伴い、近年一般的になってきています。大規模トランスフェクション・プロセスに関連する数多くの課題があるため、生産量を増やすための最良のアプローチは、プロセスの規模を拡大することではなく、むしろプロセスを縮小することです。このトップダウン・アプローチにより、トランスフェクション複合溶液の量など、工業レベルでのプロセスに影響を与える条件を明確に特定することができます。このアプローチはまた、プロセスの最適化と意思決定を容易にします。小規模トランスフェクションプロセスを強化するためのこのようなアプローチの開拓は、欧州のトランスフェクション試薬・機器市場の成長機会となります。

欧州のトランスフェクション試薬・機器市場概要

欧州地域は、英国、ドイツ、フランス、スペイン、イタリア、その他欧州に区分されます。2022年の市場シェアは英国が最大。製薬業界の成長は、同国で進められている質の高い研究開発と、広範で盛んなヘルスケア知識基盤によって決定されます。英国は、先進的治療薬の研究開発、製造、臨床採用、償還において世界最高のエコシステムのひとつです。現在、英国では85以上の臨床試験が進行中で、70のCGT企業が治癒の可能性のある治療法の開発に努力しています。カタパルトは、英国のCGTエコシステムに大きく貢献しているトップ企業であり、試薬やデバイスの製造プロセス開発に携わる企業としては、英国でトップ5に入る。同社は、最小限の介入で変化する環境やプロセス要件に自動的に適応できる、よりスマートな自動CGT製造プロセスの開発に注力しています。そのため、英国に拠点を置く企業による生産性向上と最終製品コスト削減への取り組みが、英国における細胞・遺伝子治療市場の成長を促す主な要因となっています。さらに、英国は研究への持続的かつ的を絞った投資により、欧州の細胞・遺伝子治療市場で確固たる地位を占めており、これがさらに市場に利益をもたらしています。

さらにフランスには、Sanofi S.A.、Ipsen、Pierre Fabre、HRA Pharma、TxCell（Sangamo Therapeutics, Inc.）といったバイオ医薬品・製薬大手が進出しています。これらの企業はワクチンや抗体などの開発に携わっており、製品の凍結乾燥を必要とするため、トランスフェクション試薬・機器の需要に寄与しています。

欧州のトランスフェクション試薬・機器市場の収益と2030年までの予測（金額）

欧州のトランスフェクション試薬・機器市場のセグメンテーション

欧州のトランスフェクション試薬・機器市場は、製品、手法、用途、エンドユーザー、国によって区分されます。

製品別では、欧州のトランスフェクション試薬・機器市場は試薬と機器に二分されます。試薬セグメントは2022年に大きなシェアを占めました。

手法別では、欧州のトランスフェクション試薬・機器市場は、ウイルス法、非ウイルス法、ハイブリッド法に区分されます。2022年には、非ウイルス法が最大のシェアを占めています。ウイルス法は、レトロウイルス、アデノウイルス、アデノ関連ウイルス、ヘルペスウイルスに分類されます。非ウイルス性セグメントは、物理的/機械的方法と化学的方法に二分されます。さらに、物理的／機械的方法は、エレクトロポレーション法、マイクロインジェクション法、バイオリスティック法、レーザー法、マグネトフェクション法、ソノポレーション法に細分化されます。また、化学的手法のセグメントは、リポソームベース/高脂質ベースと非リポソーム/高脂質ベースに細分化されます。

用途別では、欧州のトランスフェクション試薬・機器市場は、生物医学研究、タンパク質生産、治療デリバリーに区分されます。バイオメディカル研究セグメントが2022年に最大のシェアを占めました。

エンドユーザーに基づくと、欧州のトランスフェクション試薬・機器市場は学術・研究機関と製薬・バイオテクノロジー企業に二分されます。2022年には学術・研究機関セグメントが大きなシェアを占めています。

国別に見ると、欧州のトランスフェクション試薬・機器市場はドイツ、フランス、英国、イタリア、スペイン、その他欧州に分類されます。英国は2022年の欧州のトランスフェクション試薬・機器市場を独占しました。

Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG、MaxCyte Inc、Polyplus-Transfection SAは、欧州のトランスフェクション試薬・機器市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のトランスフェクション試薬・機器市場- 主な市場力学

  • 欧州のトランスフェクション試薬・機器市場：主要市場力学
  • 市場促進要因
    • 細胞治療と遺伝子治療の人気の高まり
    • がんの経済的負担の増大
  • 市場抑制要因
    • 機器および消耗品の高コスト
  • 市場機会
    • 小規模プロセスから大規模プロセスへの拡大
  • 今後の動向
    • 企業の戦略的取り組み
  • 促進要因と抑制要因の影響

第5章 トランスフェクション試薬・機器市場：欧州市場分析

  • 欧州のトランスフェクション試薬・機器市場の収益、2022-2030年
  • 欧州のトランスフェクション試薬・機器市場予測分析

第6章 欧州のトランスフェクション試薬・機器市場分析：製品別

  • 試薬
  • 装置

第7章 欧州のトランスフェクション試薬・機器市場分析：モダリティ別

  • ウイルス
  • 非ウイルス
  • ハイブリッド

第8章 欧州のトランスフェクション試薬・機器市場分析：用途別

  • 生物医学研究
  • タンパク質生産
  • 治療デリバリー

第9章 欧州のトランスフェクション試薬・機器市場分析：エンドユーザー別

  • 学術・研究機関
  • 製薬・バイオテクノロジー企業

第10章 欧州のトランスフェクション試薬・機器市場：国別分析

  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州

第11章 トランスフェクション試薬・機器市場：業界情勢

  • トランスフェクション試薬・機器市場における成長戦略、2020～2023年
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Polyplus-Transfection SA

第13章 付録

図表

List Of Tables

  • Table 1. Europe Transfection Reagents and Equipment Market Segmentation
  • Table 2. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
  • Table 5. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
  • Table 6. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
  • Table 7. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
  • Table 8. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
  • Table 9. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 10. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
  • Table 11. Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 12. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 13. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 14. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 15. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 16. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 17. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 18. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 20. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 21. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 22. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 23. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 24. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 25. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 26. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 27. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 28. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 30. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 31. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 32. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 33. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 34. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 35. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 36. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 38. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 39. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 40. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 41. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 42. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 43. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 44. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 45. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 46. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 47. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 48. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 49. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 50. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 51. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 52. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 53. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 54. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 55. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 56. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 57. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 58. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 59. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
  • Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List Of Figures

  • Figure 1. Europe Transfection Reagents and Equipment Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • Figure 4. Europe Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
  • Figure 5. Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Europe Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
  • Figure 8. Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Physical/Mechanical: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
  • Figure 26. Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
  • Figure 30. Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Europe: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
  • Figure 33. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 34. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
目次
Product Code: BMIRE00030436

The Europe transfection reagents and equipment market was valued at US$ 306.04 million in 2022 and is expected to reach US$ 555.46 million by 2030; it is estimated to register at a CAGR of 7.7% from 2022 to 2030.

Strategic Initiatives by Companies Drive Europe Transfection Reagents and Equipment Market

Transfection is the complex step in the overall process of developing a viral vector, which includes adenovirus, adeno-associated virus, and lentivirus. As the manufacturing processes are scaled up, transient transfection must also be ramped up. Process equipment vendors, drug developers, and raw material suppliers are focusing on collaborations to develop cost-effective, practical, and platformizable solutions for the rapid development and scaling up of viral vector manufacturing processes. On small scales, with planned material volumes and transfer & mixing times, transfecting cells with multiple plasmids becomes feasible. Scaling up requires experience in industrializing the transfection step since most companies only have transfection experience at the lab level. However, the volume of cell-culture media and transfection reagents required for scaling up the process to a larger level can be impractical, which emphasizes the need for optimization. Nonetheless, broadening the scale of production has become common in recent years with the surging demand for viral vectors. With numerous challenges associated with large-scale transfection processes, the best approach to increase production is by reducing the process rather than scaling up the process. This top-down approach allows clear identification of the conditions that will impact the process at the industrial level such as the volume of transfection complex solution. This approach also facilitates process optimization and decision-making. The development of such approaches to ramp up the small-scale transfection processes acts as an opportunity for the growth of the Europe transfection reagents and equipment market.

Europe Transfection Reagents and Equipment Market Overview

Europe region segmented into UK, Germany, France, Spain, Italy, and Rest of Europe. United Kingdom holds the largest market share in the year 2022. The growth of the pharmaceutical industry is determined by the high-quality research and development ongoing in the country, and extensive and flourishing healthcare knowledge base. The UK is one of the world's best ecosystems for research, development, manufacturing, clinical adoption, and reimbursement of advanced therapeutics. Currently, over 85 clinical trials are ongoing in the UK, and 70 CGT companies are striving to develop potentially curative therapies. Catapult is a top company that has been contributing significantly to the CGT ecosystem in the UK; it stands as one of the top five companies involved in developing manufacturing processes of reagents and devices in the country. The company is focused on developing smarter automated CGT manufacturing processes that can automatically adapt to changing environments and process requirements with minimal intervention. Therefore, efforts made by UK-based companies to enhance productivity and reduce final product costs are the major factors driving the growth of the cell and gene therapy market in the UK. Moreover, the UK holds a strong position in the cell and gene therapy market in Europe owing to sustained and targeted investment in research, which further benefits the market.

Moreover, France has the presence of biopharmaceutical and pharmaceutical giants such as Sanofi S.A., Ipsen, Pierre Fabre, HRA Pharma, and TxCell (Sangamo Therapeutics, Inc.). These companies are involved in the development of vaccines and antibodies, among others, which require freeze-drying for their products, which contributes to the demand for transfection reagents and equipment.

Europe Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)

Europe Transfection Reagents and Equipment Market Segmentation

The Europe transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

Based on product, the Europe transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

In terms of method, the Europe transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the Europe transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

Based on end user, the Europe transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

Based on country, the Europe transfection reagents and equipment market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The UK dominated the Europe transfection reagents and equipment market in 2022.

Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA are some of the leading companies operating in the Europe transfection reagents and equipment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Transfection Reagents and Equipment Market - Key Market Dynamics

  • 4.1 Europe Transfection Reagents and Equipment Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Cell and Gene Therapy
    • 4.2.2 Growing Economic Burden of Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments and Consumables
  • 4.4 Market Opportunities
    • 4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
  • 4.5 Future Trends
    • 4.5.1 Strategic Initiatives by Companies
  • 4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - Europe Market Analysis

  • 5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • 5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis

6. Europe Transfection Reagents and Equipment Market Analysis - by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Equipment
    • 6.2.1 Overview
    • 6.2.2 Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Transfection Reagents and Equipment Market Analysis - by Modality

  • 7.1 Viral
    • 7.1.1 Overview
    • 7.1.2 Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Non-Viral
    • 7.2.1 Overview
    • 7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Hybrid
    • 7.3.1 Overview
    • 7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Transfection Reagents and Equipment Market Analysis - by Application

  • 8.1 Biomedical Research
    • 8.1.1 Overview
    • 8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Protein Production
    • 8.2.1 Overview
    • 8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Therapeutic Delivery
    • 8.3.1 Overview
    • 8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Transfection Reagents and Equipment Market Analysis - by End Users

  • 9.1 Academic and Research Institutes
    • 9.1.1 Overview
    • 9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Pharmaceutical and Biotechnological Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Transfection Reagents and Equipment Market -Country Analysis

  • 10.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.2 United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.3 Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.4 France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.5 Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.6 Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.7 Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Mirus Bio LLC
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 QIAGEN NV
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Merck KGaA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lonza Group AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MaxCyte Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Polyplus-Transfection SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us